on 24 Mar 2020
Last Applicant/ Owned by
No. 168, Dongping Street,
CN
Serial Number
79234854 filed on 16th Apr 2018
Registration Number
6015574 registered on 24th Mar 2020
Correspondent Address
Anessa Owen Kramer
Filing Basis
No Filing Basis
Disclaimer
NO DATA
Medicines for human purposes, namely, antibody preparations, protein preparations, blood preparations, hormones, enzymes, toxoids, organic compounds and hemopoietic growth factors, namely, medicines for the treatment of tumor, ophthalmologic diseases, immunological mediated diseases, metabolic diseases, blood diseases, diabetes, endocrine disease, reproductive system disease, central and peripheraRead More
Medicines for human purposes, namely, antibody preparations, protein preparations, blood preparations, hormones, enzymes, toxoids, organic compounds and hemopoietic growth factors, namely, medicines for the treatment of tumor, ophthalmologic diseases, immunological mediated diseases, metabolic diseases, blood diseases, diabetes, endocrine disease, reproductive system disease, central and peripheral nervous system disease, hereditary diseases, and antiviral drugs; Pharmaceutical preparations, namely, antibody preparations, protein preparation, blood preparations, hormones, enzymes, toxoids, organic compounds and hemopoietic growth factors, namely, medicines for the treatment of tumor, ophthalmologic diseases, immunological mediated diseases, metabolic diseases, blood diseases, diabetes, endocrine disease, reproductive system disease, central and peripheral nervous system disease, hereditary diseases, and antiviral drugs; Vaccines; drugs for medical purposes, namely, antibody preparations, protein preparation, blood preparations, hormones, enzymes, toxoids, organic compounds and hemopoietic growth factors, namely, medicines for the treatment of tumor, ophthalmologic diseases, immunological mediated diseases, metabolic diseases, blood diseases, diabetes, endocrine disease, reproductive system disease, central and peripheral nervous system disease, hereditary diseases, and antiviral drugs; Biological preparations for medical purposes, namely, antibody preparations, protein preparation, blood preparations, hormones, enzymes, toxoids, organic compounds and hemopoietic growth factors, namely, medicines for the treatment of tumor, ophthalmologic diseases, immunological mediated diseases, metabolic diseases, blood diseases, diabetes, endocrine disease, reproductive system disease, central and peripheral nervous system disease, hereditary diseases, and antiviral drugs; Diagnostic preparations for medical purposes; Biological tissue cultures for medical purposes; Chemical reagents for medical purposes; all of the aforesaid excluding goods in gaseous form, goods related to nitric oxide, and veterinary products, preparations, reagents, and medicine for animal health
No 79234854
No Service/Collective Mark
No 457367
No
No
No
No
No
No
No
No
26.01.04 -
Circles with two breaks or divided in the middle
26.01.09 -
Geometric figures, objects, humans, plants or animals forming or bordering the perimeter of a circle
26.01.26 -
Spirals, coils and swirls
26.17.09 -
Curved line(s), band(s) or bar(s)
27.03.01 -
Geometric figures forming letters or numerals, including punctuation
The trademark consists of the English letters of "I", "N", "N", "O", "V", "E", "N" and "T", in which the English letter "O" is designed by two symmetrical arcs. The mark has no particular meaning when taken as a whole.
| Status Date | Action Taken |
|---|---|
| 31st Jul 2020 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| 10th Jul 2020 | FINAL DISPOSITION NOTICE SENT TO IB |
| 10th Jul 2020 | FINAL DISPOSITION PROCESSED |
| 25th Jun 2020 | NEW REPRESENTATIVE AT IB RECEIVED |
| 24th Jun 2020 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| 24th Mar 2020 | REGISTERED-PRINCIPAL REGISTER |
| 07th Jan 2020 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 07th Jan 2020 | PUBLISHED FOR OPPOSITION |
| 03rd Jan 2020 | NOTIFICATION PROCESSED BY IB |
| 18th Dec 2019 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
